The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed.
AlloSource launched AlloFuse® Cortical Fibers and AlloFuse Fiber Boat demineralized cortical fiber allografts for a variety of spine and orthopaedic procedures.Â
curasan will invest in targeted expansion of sales and marketing activities in the U.S. and China. The company markets CERASORB® bone void filler products.
Titan Spine is amending its device warranty to provide a free replacement if any Endoskeleton® interbody fusion devices delaminate or generate particulate debris during implantation.Â
SI-BONE received FDA 510(k) clearance of a modified indication for the iFuse Implant System®, noting that clinical studies have demonstrated its ability to improve pain, patient function and quality of life.Â
Corin received FDA 510(k) clearance to market the Optimized Positioning System (OPSâ„¢), reportedly the first FDA-cleared technology to support functional, patient-specific component alignment in total hip replacement.